Meningococcal Vaccine Trial

Neisseria meningitidis or meningococcus is a family of germs (bacteria) that can cause meningitis, which is an infection of the surface of the brain. While meningitis is a rare infection, it can be life-threatening and lead to permanent disability. In addition, these germs can also cause an infection of the blood, called sepsis. The different groups in the meningococcus family are indicated by letters, and the most common groups that can cause disease are called A, B, C, W and Y.

The study will compare the the ability of your body to produce antibodies against the study vaccines and safety of the new liquid formulation of the study vaccine with that of the currently licensed formulation. The study will last about six months for each participant.

Therapeutic / Disease area: Diabetes, Nephrology

Condition: Meningococcal Disease Vaccine

Locations: Blacktown (NSW), Wyong (NSW)

Commencement date: 01/04/2017

Status: Recruitment closed

Recommend this trial to your friend

For privacy purposes, please note that your friend's details will not be sent to us and will not be stored in our database. Please be assured that we will not contact them.

I have read the Privacy Policy.

Register interest in future trials

I have read the Privacy Policy.